Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × Starch × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Influenza, Human 1

Interventions

Influenza Vaccines 3 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 vaxigrip 1 thymoglobulin 1 peginterferon alfa-2a 1 influvac 1 fludarabine 1 Vaccines 1 Starch 1 SARS-CoV-2 inactivated vaccines 1 Rituximab 1 Oseltamivir 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Interferons 1 Interferon alpha-2 1 Cyclophosphamide 1 Celecoxib 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02108366 2019-10-21

Treatment of Severe Influenza A Infection

The University of Hong Kong

Phase 3 Completed

Influenza, Human, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡